89 related articles for article (PubMed ID: 21273640)
21. [Novel biological involvements of siderophore-binding proteins in hematopoiesis, cell differentiation, tissue injury, carcinogenesis and infections].
Mori K; Mukoyama M; Nakao K
Rinsho Ketsueki; 2009 Jul; 50(7):519-26. PubMed ID: 19638718
[No Abstract] [Full Text] [Related]
22. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN.
Brewer CA; Liao SY; Wilczynski SP; Pastorekova S; Pastorek J; Zavada J; Kurosaki T; Manetta A; Berman ML; DiSaia PJ; Stanbridge EJ
Gynecol Oncol; 1996 Dec; 63(3):337-44. PubMed ID: 8946869
[TBL] [Abstract][Full Text] [Related]
23. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.
Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
Int J Cancer; 2011 Apr; 128(8):1935-45. PubMed ID: 20560137
[TBL] [Abstract][Full Text] [Related]
24. Over-expression of nm23-H1 in HeLa cells provides cells with higher resistance to oxidative stress possibly due to raising intracellular p53 and GPX1.
An R; Chu YL; Tian C; Dai XX; Chen JH; Shi Q; Han J; Dong XP
Acta Pharmacol Sin; 2008 Dec; 29(12):1451-8. PubMed ID: 19026164
[TBL] [Abstract][Full Text] [Related]
25. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells.
Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW
Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321
[TBL] [Abstract][Full Text] [Related]
26. Deregulated LAP2α expression in cervical cancer associates with aberrant E2F and p53 activities.
Ward MC; van der Watt PJ; Tzoneva G; Leaner VD
IUBMB Life; 2011 Nov; 63(11):1018-26. PubMed ID: 21990273
[TBL] [Abstract][Full Text] [Related]
27. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.
Kubben FJ; Sier CF; Hawinkels LJ; Tschesche H; van Duijn W; Zuidwijk K; van der Reijden JJ; Hanemaaijer R; Griffioen G; Lamers CB; Verspaget HW
Eur J Cancer; 2007 Aug; 43(12):1869-76. PubMed ID: 17604154
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
29. [Expressions of nm23, P53 and S100A4 proteins and their relationships with metastasis potential in gastric carcinoma].
Yu GZ; Wang JJ; Chen Y; Ni CR; Zhu MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):165-9. PubMed ID: 16555162
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
Huang Y; Cai S; Yu S
Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
[TBL] [Abstract][Full Text] [Related]
31. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
32. Nm23-H1 protein binds to APE1 at AP sites and stimulates AP endonuclease activity following ionizing radiation of the human lung cancer A549 cells.
Zhang ZM; Yang XQ; Wang D; Wang G; Yang ZZ; Qing Y; Yang ZX; Li MX; Xiang DB
Cell Biochem Biophys; 2011 Dec; 61(3):561-72. PubMed ID: 21769563
[TBL] [Abstract][Full Text] [Related]
33. [Potential of novel antimycobacterial immune factors, SLPI and lipocalin 2].
Saiga H; Takeda K
Kekkaku; 2010 Jun; 85(6):523-30. PubMed ID: 20662248
[TBL] [Abstract][Full Text] [Related]
34. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
35. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
[TBL] [Abstract][Full Text] [Related]
36. Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells.
Venkatesha S; Hanai J; Seth P; Karumanchi SA; Sukhatme VP
Mol Cancer Res; 2006 Nov; 4(11):821-9. PubMed ID: 17114340
[TBL] [Abstract][Full Text] [Related]
37. Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells.
Lee HJ; Lee EK; Lee KJ; Hong SW; Yoon Y; Kim JS
Int J Cancer; 2006 May; 118(10):2490-7. PubMed ID: 16381001
[TBL] [Abstract][Full Text] [Related]
38. Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-H1 gene silencing.
Ma W; Chen J; Xue X; Wang Z; Liu H; Wang T; Bai Y; Tang SC; Zhou Q
Biochem Biophys Res Commun; 2008 Jul; 371(3):425-30. PubMed ID: 18440302
[TBL] [Abstract][Full Text] [Related]
39. Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome.
Jang Y; Lee JH; Wang Y; Sweeney G
Clin Exp Pharmacol Physiol; 2012 Feb; 39(2):194-9. PubMed ID: 21689137
[TBL] [Abstract][Full Text] [Related]
40. FTS (fused toes homolog) a novel oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer.
Cinghu S; Anandharaj A; Lee HC; Yu JR; Park WY
J Cell Physiol; 2011 Jun; 226(6):1564-72. PubMed ID: 20945372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
